Expertise in
1
conditions

Pierre Kalfon

Aubagne, FR 
Expertise in
1
conditions
Aubagne, FR 

Overview

Pierre Kalfon practices practicing medicine in Aubagne, France.

Mr. Kalfon is highly rated in 1 condition, according to our data. His clinical expertise encompasses Cerebral Hypoxia, Pneumonia, Toxic Shock Syndrome, and Low Blood Sugar.

He is actively involved in clinical research, co-authoring 39 peer reviewed articles and participating in 6 clinical trials.

Gender

Male

Locations

Aubagne, France
Other Locations
Marseille, France
Chartres, 28018, France
Le Coudray, France
Equipe Avenir 3830, Chartres, Fort De France, Angers, France
Paris, France

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

6 Clinical Trials

Guided Fluid-balance Optimization With Mini-fluid chALlenge During Septic Shock: A Multicenter, Stepped Wedge Cluster Randomized Trial
Guided Fluid-balance Optimization With Mini-fluid chALlenge During Septic Shock: A Multicenter, Stepped Wedge Cluster Randomized Trial
Enrollment Status: Completed
Publish Date: September 19, 2025
Intervention Type: Other
Study Phase: Not Applicable
L-carnitine as an Adjunct Treatment for Septic Shock Patients With Acute Kidney Injury: a Multicentre, Randomized, 2-parallel Group, Superiority Trial
L-carnitine as an Adjunct Treatment for Septic Shock Patients With Acute Kidney Injury: a Multicentre, Randomized, 2-parallel Group, Superiority Trial
Enrollment Status: Terminated
Publish Date: August 26, 2025
Intervention Type: Drug
Study Drug: L-Carnitine
Study Phase: Phase 3
Post Traumatic Early Use of High Flow Oxygenation Versus Standard Oxygen for Management of Moderately Hypoxemic Thoracic Trauma: TrOMaTho Study
Post Traumatic Early Use of High Flow Oxygenation Versus Standard Oxygen for Management of Moderately Hypoxemic Thoracic Trauma: TrOMaTho Study
Enrollment Status: Active_not_recruiting
Publish Date: May 14, 2025
Intervention Type: Device
Study Phase: Not Applicable
Efficacy of Intravenous Almitrine in Reducing the Need for Mechanical Ventilation in Patients With Hypoxemic Acute Respiratory Failure Due to Covid-19-related Pneumonia: a Randomized Controlled Double-blind Study From the Skip-icu Consortium
Efficacy of Intravenous Almitrine in Reducing the Need for Mechanical Ventilation in Patients With Hypoxemic Acute Respiratory Failure Due to Covid-19-related Pneumonia: a Randomized Controlled Double-blind Study From the Skip-icu Consortium
Enrollment Status: Completed
Publish Date: May 03, 2022
Intervention Type: Drug
Study Drug: Almitrine
Study Phase: Phase 3
Tailored Multicomponent Program for Discomfort Reduction in Critically il Patients May Decrease Post-traumatic Stress Disorder in General ICU Survivors at One Year
Tailored Multicomponent Program for Discomfort Reduction in Critically il Patients May Decrease Post-traumatic Stress Disorder in General ICU Survivors at One Year
Enrollment Status: Unknown
Publish Date: March 23, 2022
Intervention Type: Other
Study Phase: Not Applicable
Improve the Quality of Life After a Hospitalization in Critical Care Thanks to a Program of Prevention of Discomforts Perceived by the Patients of Critical Care Base on Targeted Measures
Improve the Quality of Life After a Hospitalization in Critical Care Thanks to a Program of Prevention of Discomforts Perceived by the Patients of Critical Care Base on Targeted Measures
Enrollment Status: Completed
Publish Date: July 24, 2017
Intervention Type: Other
View 5 Less Clinical Trials

39 Total Publications

Correction: Impact of self-perceived discomfort in critically ill patients on the occurrence of psychiatric symptoms in post-intensive care syndrome (PICS): A prospective observational study.
Correction: Impact of self-perceived discomfort in critically ill patients on the occurrence of psychiatric symptoms in post-intensive care syndrome (PICS): A prospective observational study.
Journal: PloS one
Published: September 15, 2025

Frequently Asked Questions about Pierre Kalfon

Is Pierre Kalfon a top-rated expert for Cerebral Hypoxia?

MediFind is an objective health platform that identifies experts based on real-world data. Pierre Kalfon is classified as an Advanced expert for Cerebral Hypoxia, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Pierre Kalfon participate in research or clinical trials?

Yes. Pierre Kalfon has published 39 articles and abstracts on conditions like Cerebral Hypoxia. You can view a list of Pierre Kalfon's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Kalfon's expertise for a condition
ConditionClose
      View All 10 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile